Dysmetabolic hepatosiderosis;Hépatosidérose dysmétabolique

Hepato-Gastro

Volumn 15, Issue 1, 2008, Pages 19-24

  Deugnier, Yves ^a,b   Bonnet, Fabrice ^a   Laine, Fabrice ^b  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSMETABOLIC HEPATOSIDEROSIS; EUROPE; FATTY LIVER; HUMAN; HYPERFERRITINEMIA; INSULIN RESISTANCE; LIVER BIOPSY; LIVER FIBROSIS; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PATHOPHYSIOLOGY; PHLEBOTOMY; PREVALENCE; RISK ASSESSMENT; SHORT SURVEY;

EID: 38949099078     PISSN: 12537020     EISSN: None     Source Type: Journal    
DOI: 10.1684/hpg.2008.0179     Document Type: Short Survey

References (39)

1. Mendler MH, Turlin B, Moirand R, Jouanolle AM, Sapey T, Guyader D, et al. Insulin resistance-associated hepatic iron overload. Gastroenterology 1999 ; 117 : 1155-63.
2. Assmann G, Guerra R, Fox G, Cullen P, Schulte H, Willett D, et al. Harmonizing the definition of the metabolic syndrome : comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. Am J Cardiol 2007 ; 99 : 541-8.
3. Bozzini C, Girelli D, Olivieri O, Martinelli N, Bassi A, De Matteis G, et al. Prevalence of body iron excess in the metabolic syndrome. Diabetes Care 2005 ; 28 : 2061-3.
4. Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Fociani P, et al. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol 2001 ; 96 : 2448-55.
5. Moirand R, Mortaji AM, Loréal O, Paillard F, Brissot P, Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet 1997 ; 349 : 95-7.
6. Turlin B, Mendler MH, Moirand R, Guyader D, Guillygomarc'h A, Deugnier Y. Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients. Am J Clin Pathol 2001 ; 116 : 263-70.
7. Gandon Y, Olivie D, Guyader D, Aube C, Oberti F, Sebille V, et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004 ; 363 : 357-62.
8. Pietrangelo A. The ferroportin disease. Blood Cells Mol Dis 2004 ; 32 : 131-8.
9. Pietrangelo A, Corradini E, Ferrara F, Vegetti A, De Jong G, Luca Abbati G, et al. Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease. Blood Cells Mol Dis 2006 ; 37 : 192-6.
10. Guillygomarc'h A, Mendler MH, Moirand R, Jouanolle AM, David V, Deugnier Y. HFE mutations in insulin resistance-associated hepatic iron overload. J Hepatol 2000 ; 33 : 515-6.
11. Deugnier Y, Loréal O, Carre F, Duvallet A, Zoulim F, Vinel JP, et al. Increased body iron stores in elite road cyclists. Med Sci Sports Exerc 2002 ; 34 : 876-80.
12. Bridle K, Cheung TK, Murphy T, Walters M, Anderson G, Crawford DG, et al. Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease. Alcohol Clin Exp Res 2006 ; 30 : 106-12.
13. Kunde SS, Lazenby AJ, Clements RH, Abrams GA. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. Hepatology 2005 ; 42 : 650-6.
14. Lainé F, Bendavid C, Moirand R, Tessier S, Perrin M, Guillygomarc'h A, et al. Prediction of liver fibrosis in patients with features of the metabolic syndrome regardless of alcohol consumption. Hepatology 2004 ; 39 : 1639-46.
15. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome : further evidence for an etiologic association. Hepatology 2002 ; 35 : 367-72.
16. Marchesini G, Marzocchi R. Metabolic syndrome and NASH. Clin Liver Dis 2007 ; 11 : 105-17.
17. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, et al. NASH and insulin resistance : Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002 ; 35 : 373-9.
18. George DK, Goldwurm S, MacDonald GA, Cowley LL, Walker NI, Ward PJ, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998 ; 114 : 311-8.
19. Fernandez-Real JM, Ricart-Engel W, Arroyo E, Balanca R, Casamitjana-Abella R, Cabrera D, et al. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care 1998 ; 21 : 62-8.
20. Wrede CE, Buettner R, Bollheimer LC, Scholmerich J, Palitzsch KD, Hellerbrand C. Association between serum ferritin and the insulin resistance syndrome in a representative population. Eur J Endocrinol 2006 ; 154 : 333-40.
21. Deugnier Y, Gandon Y, Juhel C, Olivié D, Jouanolle A, Turlin B. Diagnostic d'une surcharge en fer. Revue du Praticien 2006 ; 56 : 2118-22.
22. Iwasaki T, Nakajima A, Yoneda M, Yamada Y, Mukasa K, Fujita K, et al. Serum ferritin is associated with visceral fat area and subcutaneous fat area. Diabetes Care 2005 ; 28 : 2486-91.
23. Chen J, Wildman RP, Hamm LL, Muntner P, Reynolds K, Whelton PK, et al. Association between inflammation and insulin resistance in U.S. nondiabetic adults : results from the Third National Health and Nutrition Examination Survey. Diabetes Care 2004 ; 27 : 2960-5.
24. Roblin X, Phelip JM, Hilleret MN, Heluwaert F, Bonaz B, Zarski J-P. [Correction of insulin resistance syndrome does not cause normalisation of hyperferritinaemia]. Gastroenterol Clin Biol 2003 ; 27 : 1079-83.
25. Tanner LI, Lienhard GE. Insulin elicits a redistribution of transferrin receptors in 3T3-L1 adipocytes through an increase in the rate constant for receptor externalization. J Biol Chem 1987 ; 262 : 8975-80.
26. Korac A, Verec M, Davidovic V. Insulin-induced iron loading in the rat brown adipose tissue : histochemical and electron-microscopic study. Eur J Histochem 2003 ; 47 : 241-4.
27. Bowering J, Masch GA, Lewis AR. Enhancement of iron absorption in iron depleted rats by increasing dietary fat. J Nutr 1977 ; 107 : 1687-93.
28. Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006 ; 131 : 788-96.
29. Loréal O, Haziza-Pigeon C, Troadec MB, Detivaud L, Turlin B, Courselaud B, et al. Hepcidin in iron metabolism. Curr Protein Pept Sci 2005 ; 6 : 279-91.
30. Lainé F, Deugnier Y. Increased Expression of Hepcidin in Obese Patients : Impact on Phenotypic Expression of Hemochromatosis and Pathophysiology of Dysmetabolic Iron Overload Syndrome. Gastroenterology 2006 ; 131 : 2028.
31. Facchini FS, Hua NW, Stoohs RA. Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. Gastroenterology 2002 ; 122 : 931-9.
32. Valenti L, Fracanzani AL, Dongiovanni P, Bugianesi E, Marchesini G, Manzini P, et al. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia : evidence from a case-control study. Am J Gastroenterol 2007 ; 102 : 1251-8.
33. Lainé F, Reymann JM, Morel F, Langouet S, Perrin M, Guillygomarc'h A, et al. Effects of phlebotomy therapy on cytochrome P450 2e1 activity and oxidative stress markers in dysmetabolic iron overload syndrome : a randomized trial. Aliment Pharmacol Ther 2006 ; 24 : 1207-13.
34. Fumeron F, Pean F, Driss F, Balkau B, Tichet J, Marre M, et al. Ferritin and transferrin are both predictive of the onset of hyperglycemia in men and women over 3 years : the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study. Diabetes Care 2006 ; 29 : 2090-4.
35. Deugnier Y. Iron and liver cancer. Alcohol 2003 ; 30 : 145-50.
36. Stocks T, Lukanova A, Johansson M, Rinaldi S, Palmqvist R, Hallmans G, et al. Components of the metabolic syndrome and colorectal cancer risk ; a prospective study. Int J Obes (Lond) 2007 ; (in press).
37. Guillygomarc'h A, Mendler MH, Moirand R, Lainé F, Quentin V, David V, et al. Venesection therapy of insulin resistance-associated hepatic iron overload. J Hepatol 2001 ; 35 : 344-9.
38. Olsson KS. Iron stores in normal men and male blood donors. As measured by desferrioxamine and quantitative phlebotomy. Acta Med Scand 1972 ; 192 : 401-7.
39. Massart C, Bendavid C, Gibassier J, Perrin M, Deugnier Y, Lainé F. Importance of the functional sensitivity determination of a serum hyaluronic acid assay for the prediction of liver fibrosis in patients with features of the metabolic syndrome. Clin Chem Lab Med 2006 ; 44 : 506-7.